| scholarly article | Q13442814 |
| P2093 | author name string | E White | |
| P Sabbatini | |||
| A B Rabson | |||
| B A Antoni | |||
| P2860 | cites work | Pathogenesis of human immunodeficiency virus infection | Q24634681 |
| The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus | Q28259668 | ||
| Role of adenovirus E1B proteins in transformation: altered organization of intermediate filaments in transformed cells that express the 19-kilodalton protein | Q29541648 | ||
| Cell death: the significance of apoptosis | Q29617620 | ||
| The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain | Q29618472 | ||
| The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis | Q29618601 | ||
| The immunopathogenesis of human immunodeficiency virus infection | Q34060285 | ||
| Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1 | Q34188750 | ||
| Apoptotic cell death induced by c-myc is inhibited by bcl-2. | Q34255589 | ||
| Cooperative interaction between c-myc and bcl-2 proto-oncogenes | Q34255596 | ||
| Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene | Q34325670 | ||
| Programmed cell death and AIDS: from hypothesis to experiment | Q35268349 | ||
| Virus proteins that counteract host immune defenses | Q35369721 | ||
| Bcl-2: a repressor of lymphocyte death | Q35755694 | ||
| Conformational changes induced in the human immunodeficiency virus envelope glycoprotein by soluble CD4 binding | Q36230268 | ||
| Activation-induced death by apoptosis in CD4+ T cells from human immunodeficiency virus-infected asymptomatic individuals | Q36230977 | ||
| Crosslinking CD4 by human immunodeficiency virus gp120 primes T cells for activation-induced apoptosis | Q36231815 | ||
| Bcl-2 and the regulation of programmed cell death | Q36233600 | ||
| Biological and biochemical characterization of a cloned Leu-3- cell surviving infection with the acquired immune deficiency syndrome retrovirus | Q36352167 | ||
| Selective anergy of V beta 8+ T cells in human immunodeficiency virus-infected individuals | Q36362794 | ||
| Functional complementation of the adenovirus E1B 19-kilodalton protein with Bcl-2 in the inhibition of apoptosis in infected cells | Q36636274 | ||
| Adenovirus E1B 19-kilodalton protein overcomes the cytotoxicity of E1A proteins | Q36693914 | ||
| Staphylococcal exotoxin superantigens induce human immunodeficiency virus type 1 expression in naturally infected CD4+ T cells | Q36702187 | ||
| Contribution of NF-kappa B and Sp1 binding motifs to the replicative capacity of human immunodeficiency virus type 1: distinct patterns of viral growth are determined by T-cell types | Q36797366 | ||
| The 19-Kilodalton Adenovirus E1B Transforming Protein Inhibits Programmed Cell Death and Prevents Cytolysis by Tumor Necrosis Factor α | Q36816831 | ||
| In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity | Q36825840 | ||
| Mutations in the gene encoding the adenovirus early region 1B 19,000-molecular-weight tumor antigen cause the degradation of chromosomal DNA. | Q36895508 | ||
| Deletion of the gene encoding the adenovirus 5 early region 1b 21,000-molecular-weight polypeptide leads to degradation of viral and host cell DNA | Q36896010 | ||
| Nuclear envelope localization of an adenovirus tumor antigen maintains the integrity of cellular DNA | Q36955675 | ||
| The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins | Q37162513 | ||
| Modulation of p53-mediated transcriptional repression and apoptosis by the adenovirus E1B 19K protein | Q40021698 | ||
| The human T-cell leukemia virus type I Tax protein induces apoptosis which is blocked by the Bcl-2 protein | Q40040736 | ||
| The E1B 19,000-molecular-weight protein of group C adenoviruses prevents tumor necrosis factor cytolysis of human cells but not of mouse cells | Q40064866 | ||
| Regulation of Apoptosis by the Transforming Genes of the DNA Tumor Virus Adenovirus | Q40489935 | ||
| Multifactorial nature of human immunodeficiency virus disease: implications for therapy | Q40777913 | ||
| New concepts in AIDS pathogenesis | Q40895666 | ||
| Induction of developmentally programmed cell death and activation of HIV by sodium butyrate | Q41457611 | ||
| Bcl-2 blocks p53-dependent apoptosis | Q41476333 | ||
| Lipid hydroperoxides induce apoptosis in T cells displaying a HIV-associated glutathione peroxidase deficiency. | Q41494636 | ||
| HIV-1 induces down-regulation of bcl-2 expression and death by apoptosis of EBV-immortalized B cells: a model for a persistent "self-limiting" HIV-1 infection | Q41497696 | ||
| HIV-1 infection of human CD4+ T cells in vitro. Differential induction of apoptosis in these cells. | Q41503362 | ||
| Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I. | Q41515028 | ||
| HIV gene expression enhances T cell susceptibility to hydrogen peroxide-induced apoptosis | Q41518745 | ||
| Membrane expression of HIV envelope glycoproteins triggers apoptosis in CD4 cells | Q41539200 | ||
| A novel protein domain required for apoptosis. Mutational analysis of human Fas antigen | Q41553101 | ||
| Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. | Q41563742 | ||
| Stabilization of the p53 tumor suppressor is induced by adenovirus 5 E1A and accompanies apoptosis | Q41563751 | ||
| Conversion of lytic to persistent alphavirus infection by the bcl-2 cellular oncogene | Q41572703 | ||
| Participation of tyrosine phosphorylation in the cytopathic effect of human immunodeficiency virus-1 | Q41628339 | ||
| Cell-to-cell spread of HIV-1 occurs within minutes and may not involve the participation of virus particles | Q41642255 | ||
| An HIV-1-infected T cell clone defective in IL-2 production and Ca2+ mobilization after CD3 stimulation. | Q41657915 | ||
| Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death | Q41678654 | ||
| The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody | Q41690042 | ||
| Dissociation of gp120 from HIV-1 virions induced by soluble CD4. | Q41714439 | ||
| pH-independent HIV entry into CD4-positive T cells via virus envelope fusion to the plasma membrane | Q41764642 | ||
| Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells | Q41975913 | ||
| Monokine regulation of human immunodeficiency virus-1 expression in a chronically infected human T cell clone | Q42813546 | ||
| Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity | Q43894349 | ||
| Accelerated apoptosis in peripheral blood mononuclear cells (PBMCs) from human immunodeficiency virus type-1 infected patients and in CD4 cross-linked PBMCs from normal individuals. | Q45783432 | ||
| The cytopathic effect of HIV is associated with apoptosis. | Q50799294 | ||
| An improved colorimetric assay for interleukin 2. | Q50906708 | ||
| Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. | Q53437454 | ||
| Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein. | Q53534022 | ||
| Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line. | Q53791769 | ||
| Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen | Q59073026 | ||
| Programmed death of T cells in HIV-1 infection | Q67518695 | ||
| Mechanisms of HIV-1 latency | Q68068640 | ||
| Morphometric analysis of recombinant soluble CD4-mediated release of the envelope glycoprotein gp120 from HIV-1 | Q68622570 | ||
| The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level | Q70213932 | ||
| Apoptosis in AIDS | Q72218940 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | apoptotic process | Q14599311 |
| P304 | page(s) | 2384-2392 | |
| P577 | publication date | 1995-04-01 | |
| P1433 | published in | Journal of Virology | Q1251128 |
| P1476 | title | Inhibition of apoptosis in human immunodeficiency virus-infected cells enhances virus production and facilitates persistent infection | |
| P478 | volume | 69 |
| Q39579481 | A cytopathogenic, apoptosis-inducing variant of hepatitis A virus. |
| Q36549273 | A major human immunodeficiency virus type 1-initiated killing pathway distinct from apoptosis |
| Q41051046 | Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2. |
| Q91964280 | Analysis of networks of host proteins in the early time points following HIV transduction |
| Q28299264 | Apoptosis induction influences reovirus replication and virulence in newborn mice |
| Q37356313 | Apoptosis mediated by HIV protease is preceded by cleavage of Bcl-2 |
| Q39736809 | Apoptotic cells, including macrophages, are prominent in Theiler's virus-induced inflammatory, demyelinating lesions |
| Q37605545 | Bc1-2 protects mice against fatal alphavirus encephalitis |
| Q37275482 | Cigarette smoke alters respiratory syncytial virus-induced apoptosis and replication |
| Q77403767 | Coronavirus MHV-3-induced apoptosis in macrophages |
| Q30431042 | Cyclic regulation of apoptotic gene expression in the mouse oviduct |
| Q34338445 | Cytopathic killing of peripheral blood CD4(+) T lymphocytes by human immunodeficiency virus type 1 appears necrotic rather than apoptotic and does not require env. |
| Q34338458 | Death of CD4(+) T-cell lines caused by human immunodeficiency virus type 1 does not depend on caspases or apoptosis |
| Q35009175 | Effect of hepatitis C infection on HIV-induced apoptosis |
| Q37363445 | Extensive apoptosis in a case of intractable infantile status epilepticus |
| Q36160214 | Fas ligand deficiency in HIV disease |
| Q36366175 | HIV-induced apoptosis requires the CD4 receptor cytoplasmic tail and is accelerated by interaction of CD4 with p56lck. |
| Q24685633 | Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity |
| Q37155721 | Ingenol Protects Human T Cells From HIV-1 Infection |
| Q37881372 | Inhibition of apoptosis in chlamydia-infected cells: blockade of mitochondrial cytochrome c release and caspase activation |
| Q35716987 | Inhibitory role of the host apoptogenic gene PKR in the establishment of persistent infection by encephalomyocarditis virus in U937 cells |
| Q33783919 | Loss of CD4+ T cells in human immunodeficiency virus type 1-infected chimpanzees is associated with increased lymphocyte apoptosis |
| Q37728093 | Macrophage signaling in HIV-1 infection |
| Q40279377 | Maintenance of the HIV Reservoir Is Antagonized by Selective BCL2 Inhibition |
| Q33489541 | NGF is an essential survival factor for bronchial epithelial cells during respiratory syncytial virus infection |
| Q90244962 | Novel insights in the role of Bcl-2 homolog Nr-13 (vNr-13) encoded by herpesvirus of turkeys in the virus replication cycle, mitochondrial networks and apoptosis inhibition |
| Q22003920 | Protection against fatal Sindbis virus encephalitis by beclin, a novel Bcl-2-interacting protein |
| Q35877449 | Role of early and late replication events in induction of apoptosis by baculoviruses |
| Q39579199 | Role of the Fas/Fas ligand apoptotic pathway in human immunodeficiency virus type 1 disease |
| Q39548969 | Sendai virus infection induces apoptosis through activation of caspase-8 (FLICE) and caspase-3 (CPP32). |
| Q24650854 | T helper cell activation and human retroviral pathogenesis |
| Q36340830 | TNF-related apoptosis-inducing ligand (TRAIL) exerts therapeutic efficacy for the treatment of pneumococcal pneumonia in mice |
| Q33839175 | The SH integral membrane protein of the paramyxovirus simian virus 5 is required to block apoptosis in MDBK cells |
| Q35864541 | bc1-2 expression facilitates human immunodeficiency virus type-1 mediated cytopathic effects during acute spreading infections |
Search more.